Integra LifeSciences
Builds neurosurgery, ENT, surgical-instrument and regenerative tissue products.
$16.89
After-hours close0.00 (0.00%)
At close$16.89(+0.24%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 97.71%Insiders 2.66%
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 77.77M · Float 58.67M · 75.4% free float
Institutions13F, as of Jun 30, 2026
212 holders · 75.99M shares · 46 new positions · 118 increased · 62 reduced · 36 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.68M | 13.74% | +364.9K | Aug 7, 2026 |
| Rubric Capital Management LP | 7.75M | 9.97% | 0 | Aug 14, 2026 |
| Invesco Ltd. | 3.75M | 4.82% | +263.8K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 3.74M | 4.81% | +56.5K | Aug 13, 2026 |
| Morgan Stanley | 3.59M | 4.62% | +8.9K | Aug 13, 2026 |
| Paradigm Capital Management Inc/NY | 3.44M | 4.42% | −573.6K | Aug 13, 2026 |
| Fuller & Thaler Asset Management, Inc. | 3.44M | 4.42% | −93.4K | Aug 12, 2026 |
| State Street Corp | 2.95M | 3.79% | +60.3K | Aug 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 13.20% | 10.28M | 13G | Jul 17, 2025 ↗ |
| Rubric Capital Management LP | 9.46% | 7.35M | 13G | Jul 9, 2025 ↗ |
| Paradigm Capital Management Inc/NY | 5.20% | 4.01M | 13G | May 15, 2026 ↗ |
| Vanguard Portfolio Management | 5.02% | 3.91M | 13G | Jul 31, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Stuart Essig | director | 1.35M | 1.74% | Aug 18, 2025 |
| Barbara B. Hill | director | 133.5K | 0.17% | May 11, 2026 |
| Keith Bradley | director | 88.3K | 0.11% | May 11, 2026 |
| Christian S. Schade | director | 70.4K | 0.09% | May 13, 2025 |
| Robert T. Jr. Davis | officer: EVP & President, TT | 66.4K | 0.09% | Mar 12, 2026 |
| Michael J. McBreen | officer: EVP & President, CSS | 60.7K | 0.08% | Mar 12, 2026 |
| Eric Schwartz | officer: EVP, Chief Legal Officer & Sec | 56.0K | 0.07% | Mar 13, 2025 |
| Lea Daniels Knight | officer: EVP & Chief Financial Officer | 45.3K | 0.06% | Jul 6, 2026 |
| Shaundra Clay | director | 41.5K | 0.05% | May 13, 2025 |
| Jeffrey A. Graves | director | 41.1K | 0.05% | Nov 6, 2025 |
3 ten-percent owners hold 24.88M shares by Form 4, outside the officers-and-directors figure above · 30 people have not refiled in the last 18 months (1.14M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Nov 5, 2025 | Jeffrey A. Gravesdirector | Purchase | 9,000 | $11.35 | 41,086 |
CongressHouse and Senate disclosures
Not reported.